In a strong show of support for the CF community, the U.S. Senate Appropriations Committee recently expressed the importance of innovative cystic fibrosis research in a spending bill, which is part of the federal budget under consideration right now in Congress.
Oct. 11, 2011
|
1 min read
Oct. 10, 2011
|
2 min read
Sept. 14, 2011
|
2 min read
Kids from 20 States Make Case for Drug Funding and Access to Care for Fatal Disease
June 22, 2011
|
2 min read
The Cystic Fibrosis Foundation's successful business model was at the center of a congressional briefing in Washington, D.C., today, which focused on strategies for jump-starting drug development for rare diseases.
June 14, 2011
|
2 min read
May 17, 2011
|
2 min read
May 6, 2011
|
1 min read
A new law that allows patients with rare diseases to participate in clinical trials without losing eligibility for public health care benefits went into effect yesterday. The bill, known as the “Improving Access to Clinical Trials Act” (IACT), was championed by the Cystic Fibrosis Foundation and signed into law in October 2010.
April 4, 2011
|
2 min read
March 22, 2011
|
2 min read